rs4925112

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_030665.4(RAI1):​c.4311T>C​(p.Pro1437Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0651 in 1,612,960 control chromosomes in the GnomAD database, including 5,087 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1534 hom., cov: 33)
Exomes 𝑓: 0.061 ( 3553 hom. )

Consequence

RAI1
NM_030665.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.11

Publications

14 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 17-17797259-T-C is Benign according to our data. Variant chr17-17797259-T-C is described in ClinVar as Benign. ClinVar VariationId is 96190.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.244 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.4311T>C p.Pro1437Pro synonymous_variant Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.4311T>C p.Pro1437Pro synonymous_variant Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16435
AN:
151972
Hom.:
1522
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0566
Gnomad ASJ
AF:
0.0277
Gnomad EAS
AF:
0.00483
Gnomad SAS
AF:
0.0248
Gnomad FIN
AF:
0.0748
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0596
Gnomad OTH
AF:
0.0943
GnomAD2 exomes
AF:
0.0605
AC:
15096
AN:
249448
AF XY:
0.0568
show subpopulations
Gnomad AFR exome
AF:
0.254
Gnomad AMR exome
AF:
0.0357
Gnomad ASJ exome
AF:
0.0284
Gnomad EAS exome
AF:
0.00285
Gnomad FIN exome
AF:
0.0783
Gnomad NFE exome
AF:
0.0592
Gnomad OTH exome
AF:
0.0577
GnomAD4 exome
AF:
0.0606
AC:
88581
AN:
1460870
Hom.:
3553
Cov.:
37
AF XY:
0.0587
AC XY:
42660
AN XY:
726728
show subpopulations
African (AFR)
AF:
0.248
AC:
8298
AN:
33480
American (AMR)
AF:
0.0386
AC:
1727
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0258
AC:
674
AN:
26136
East Asian (EAS)
AF:
0.00194
AC:
77
AN:
39700
South Asian (SAS)
AF:
0.0270
AC:
2329
AN:
86256
European-Finnish (FIN)
AF:
0.0763
AC:
4003
AN:
52442
Middle Eastern (MID)
AF:
0.0519
AC:
299
AN:
5756
European-Non Finnish (NFE)
AF:
0.0605
AC:
67281
AN:
1112002
Other (OTH)
AF:
0.0645
AC:
3893
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
5901
11801
17702
23602
29503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2546
5092
7638
10184
12730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.108
AC:
16486
AN:
152090
Hom.:
1534
Cov.:
33
AF XY:
0.107
AC XY:
7927
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.248
AC:
10297
AN:
41492
American (AMR)
AF:
0.0565
AC:
864
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
96
AN:
3466
East Asian (EAS)
AF:
0.00484
AC:
25
AN:
5162
South Asian (SAS)
AF:
0.0246
AC:
118
AN:
4796
European-Finnish (FIN)
AF:
0.0748
AC:
793
AN:
10608
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0596
AC:
4047
AN:
67952
Other (OTH)
AF:
0.0986
AC:
208
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
689
1378
2066
2755
3444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0714
Hom.:
913
Bravo
AF:
0.114
Asia WGS
AF:
0.0580
AC:
203
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Dec 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Smith-Magenis syndrome Benign:1
May 05, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.035
DANN
Benign
0.33
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4925112; hg19: chr17-17700573; API